Cargando…
Quantitative phosphoproteomics reveals genistein as a modulator of cell cycle and DNA damage response pathways in triple-negative breast cancer cells
Around one sixth of breast cancer cases are classified as triple-negative breast cancer (TNBC), named after the absence of the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2); however, patients with TNBC suffer from poor clinical...
Autores principales: | FANG, YI, ZHANG, QIAN, WANG, XIN, YANG, XUE, WANG, XIANGYU, HUANG, ZHEN, JIAO, YUCHEN, WANG, JING |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750531/ https://www.ncbi.nlm.nih.gov/pubmed/26783066 http://dx.doi.org/10.3892/ijo.2016.3327 |
Ejemplares similares
-
Differential responses to kinase inhibition in FGFR2-addicted triple negative breast cancer cells: a quantitative phosphoproteomics study
por: Cunningham, Debbie L., et al.
Publicado: (2020) -
Deciphering MET‐dependent modulation of global cellular responses to DNA damage by quantitative phosphoproteomics
por: Bensimon, Ariel, et al.
Publicado: (2020) -
Genistein suppresses the proliferation of telomerase‐negative cells
por: Lin, Chuan‐Chuan, et al.
Publicado: (2016) -
Quantitative Phosphoproteomics Reveals the Signaling Dynamics of Cell-Cycle Kinases in the Fission Yeast Schizosaccharomyces pombe
por: Swaffer, Matthew P., et al.
Publicado: (2018) -
Quantitative phosphoproteome on the silkworm (Bombyx mori) cells infected with baculovirus
por: Shobahah, Jauharotus, et al.
Publicado: (2017)